Skip to search formSkip to main contentSkip to account menu

recurrent osteosarcoma

Known as: Relapsed Osteosarcoma, Relapsed Osteogenic Sarcoma, Osteosarcoma, Recurrent 
The reemergence of osteosarcoma after a period of remission.
National Institutes of Health

Related topics

Related topics

9 relations
Connective Tissue CellsConnective and Soft TissueEpithelial CellsEpithelium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Dose‐response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium
The pediatric preclinical testing program previously demonstrated activity of eribulin in osteosarcoma patient‐derived xenograft… 
2017
2017
Nanoengineered implant as a new platform for regenerative nanomedicine using 3D well-organized human cell spheroids
In tissue engineering, it is still rare today to see clinically transferable strategies for tissue-engineered graft production… 
Review
2015
Review
2015
Tumoral calcinosis mimicking recurrent osteosarcoma
We report a case of a tumoral calcinosis mimicking the appearance of recurrent osteosarcoma of the left femur and tibia in a 29… 
Review
2009
Review
2009
Strategies to explore new approaches in the investigation and treatment of osteosarcoma.
Studies in osteosarcoma over the past 40 years have led to a steady improvement in the overall outcome of patients with… 
2006
2006
A successful case of allogeneic bone marrow transplantation for osteosarcoma with multiple metastases of lung and bone
A successful case of allogeneic bone marrow transplantation for osteosarcoma with multiple metastases of lung and bone 
2005
2005
Non‐myeloablative allogenic peripheral blood stem cell transplantation in a patient with refractory osteosarcoma
Abstract:  The prognosis of patients with relapsed osteosarcoma is dismal despite the use of intensive chemotherapy. We describe… 
2002
2002
Interleukin-1 alpha increases the cytotoxic activity of etoposide against human osteosarcoma cells.
The recurrence of pulmonary metastases resistant to salvage chemotherapy continues to be a major problem in osteosarcoma patients… 
Review
1999
Review
1999
Oncogenic Osteomalacia as a Harbinger of Recurrent Osteosarcoma
Discussion. Oncogenic osteomalacia is a rare paraneoplastic syndrome of skeletal demineralization from renal phosphate loss… 
1997
1997
Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma.
A Phase II trial using interleukin 1alpha (IL-1alpha) and etoposide for patients with relapsed osteosarcoma (OS) was undertaken… 
Highly Cited
1993
Highly Cited
1993
Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy.
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE), a new biologic response modifier, was designed to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)